Also found in: Medical.
CALGBCancer and Leukemia Group B
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Based on drug, the market is divided into Hyper-CVAD Regimen, Linker Regimen, Nucleoside Metabolic Inhibitors (Clolar and Nelarabine), Targeted Drugs & Immunotherapy, CALGB 8811 Regimen, and Oncaspar.
Bellon et al., "Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343," Journal of Clinical Oncology, vol.
The multi-kinase inhibitor midostaurin (M) prolongs survival compared with placebo (P) in combination with daunorubicin (D)/cytarabine (C) induction (ind), high-dose C consolidation (consol), and as maintenance (maint) therapy in newly diagnosed acute myeloid leukemia (AML) patients (pts) age 18-60 with FLT3 mutations (muts): an international prospective randomized (rand) P-controlled double-blind trial (CALGB 10603/ RATIFY [Alliance]).
Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).
CALGB 100104 was a phase III, controlled, double-blind, multi-centre study of 460 patients with newly diagnosed multiple myeloma undergoing ASCT who were randomised to receive continuous daily treatment with Revlimid or placebo until relapse or intolerance.
Dodge et al., "Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)," Blood, vol.
Bogart et al., "Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105," Journal of Clinical Oncology, vol.
In the Cancer and Leukemia Group B (CALGB) study evaluating HiDAC-6 consolidation, 71% of patients required hospitalization for neutropenic fever or other complications [8].
O'Byrne, "Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems," Thorax, vol.
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II: non-bulky Hodgkin lymphoma pretreatment prognostic factors and interim PET.
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803.